$BITBBullishMed

Capital B Gains Authority to Raise Up to $120B for Bitcoin

Capital B, a France-listed Bitcoin treasury company, said shareholders approved plans to raise up to 105 billion euros ($120.4 billion) to fund future Bitcoin purchases. According to the company, over 95% backed up to 5 billion euros in capital increases and up to 100 billion euros in credit instruments. Capital B said the moves aim to increase Bitcoin per fully diluted share over time.

8/10
8/10
Med
Bullish
immediately after Wednesday shareholder approval; potential follow-through on financing execution
risk-on for crypto-treasury exposure; supportive for BTC accumulation expectations

The approved capital/credit capacity increases Capital B’s ability to buy more BTC, supporting a longer-duration accumulation narrative.

Capital B shareholders approved authorizations to raise up to 105 billion euros to fund future Bitcoin purchases, enabling further BTC accumulation.

Near-term: modest support to sentiment; medium-term: potential re-rating if investors expect faster BTC per share accumulation.

Background

Capital B is described as Europe’s second-largest Bitcoin treasury company, holding 3,139 BTC, and it is seeking additional funding to expand its BTC accumulation strategy.

Why it matters

Shareholder-approved capital increases (up to 5B euros) and issuance of credit instruments (up to 100B euros) are intended to accelerate BTC accumulation focused on increasing BTC per fully diluted share over time.

Market relevance

This is a concrete financing authorization tied directly to future BTC buying capacity, which can shift valuation expectations for crypto-treasury equities.

Market effects

Reinforces the broader crypto-treasury playbook of using equity/credit capacity to increase BTC per share over time.

Highlights continued European corporate appetite for BTC treasury strategies, potentially influencing peer sentiment.

Large authorization size may marginally affect expectations for incremental corporate BTC demand, though the article cites only holdings and strategy, not immediate purchases.

Alternative perspectives

Authorization does not guarantee timing or execution; dilution and financing costs could offset any per-share BTC accumulation benefit.

The article provides authorization amounts and dilution math but not the expected cost of credit instruments, purchase schedule, or constraints that could slow BTC buying.

Key entities

  • Capital B

    France-listed Bitcoin treasury company whose shareholders approved authorizations to raise up to 105B euros for future Bitcoin purchases.

Related articles

$MSTRMedAI 8/10

Michael Saylor said ‘never sell your Bitcoin.’ Now his company, Strategy, can sell up to $1.25 billion if it needs cash

Strategy (NASDAQ:MSTR) authorized a Bitcoin sale program allowing it to sell up to $1.25 billion of its BTC to top up cash reserves under its Digital Credit Capital Framework. As of June 28 it held about $2.55 billion cash. The company says it remains committed to Bitcoin as its primary treasury reserve. The article cites Strategy filings and prior Saylor statements.

$GPUSMed

Hyperscale Data Surpasses 1,000 Bitcoin in Corporate Treasury

Hyperscale Data, Inc. (NYSE American: GPUS) said it has surpassed 1,000 bitcoin in its corporate treasury. The company attributes the strategy to improving financial flexibility, including potential collateral for future financing, and diversifying its balance sheet. It plans to continue managing and expanding its bitcoin holdings as capital allocation opportunities arise.

$ZEC-USDMed

Zcash Price Climbs Above $500 After Project Tachyon Security Update

Zcash (ZEC) rose over 10% on Tuesday after Project Tachyon developers reported progress toward a mathematical proof that Ironwood’s shielded pool is free of undetectable counterfeiting bugs. Zooko Wilcox said Ironwood is scheduled for deployment this month. ZEC traded around $496 after briefly reclaiming $500, following a prior Orchard-related drop.